FDA Approves Outlook Therapeutics' Lytenava as First Ophthalmic Bevacizumab for Wet AMD

The FDA has approved Outlook Therapeutics' Lytenava (bevacizumab-vikg) for the treatment of wet age-related macular degeneration (AMD), making it the first FDA-approved ophthalmic formulation of bevacizumab in the United States. According to Outlook, the approval provides retina specialists with an ophthalmic bevacizumab specifically developed for intravitreal use, rather than relying on repackaged formulations originally intended for intravenous administration.

Retinal Perfusion, Sensitivity, and Function in DR

Barton Blackorby, MD; Katherine Talcott, MD; and Hong-Uyen Hua, MD

Eyetube

Does retinal capillary non-perfusion reliably predict functional vision loss in DR? And does the answer change how retina specialists treat it? In this episode of New Retina Radio Journal Club with VBS, Barton Blackorby, MD; Katherine Talcott, MD; and Hong-Uyen Hua, MD, discuss a prospective longitudinal cohort study examining the association between retinal sensitivity and perfusion over 2 years in patients with DR.

Featured Podcasts

Ophthalmology off the Grid

Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field.

View Feed

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View Feed

Eyewire News: The Podcast

Get the latest information and breaking news in the ophthalmic field.

View Feed

When Ocular Allergy Strikes

Joseph Allen, OD, FAAO, Dipl ABO

Eyetube

In this episode, Joseph J. Allen, OD, FAAO, Dipl ABO, focuses on ocular allergy, a topic increasing in importance as our climate changes and, consequently, allergy prevalence heightens. He touches on how to distinguish between ocular allergy and dry eye, paying particularly close attention to patient signs and symptoms. These signs and symptoms can then help guide diagnosis and pave the way for management and treatment options, which can range from conservative to more aggressive, depending on the specific case at hand.

Study Examines Semaglutide and Wet AMD Risk

Eyetube

An international study examines the link between a popular weight loss medication and wet AMD risk; Heidelberg receives FDA clearance for a Spectralis software upgrade; and Bausch + Lomb launches its latest over-the-counter dry eye relief product in the US. Learn more about your ad choices. Visit megaphone.fm/adchoices

Eyewire News

07.24.2026

FDA Approves Outlook Therapeutics' Lytenava as First Ophthalmic Bevacizumab for Wet AMD

07.27.2026

Aravind Eye Care System, Alcon Launch Global Vitreoretinal Surgery Training Center in India

07.27.2026

Glaukos Completes Enrollment in US Pivotal Study of Preserflo MicroShunt for POAG

07.24.2026

Topcon Receives CE Mark for GAIA Ultra-Widefield Retinal Imaging System

07.24.2026

Théa, Unither Pharmaceuticals Partner on Dedicated Ophthalmic Manufacturing Facility in France

EyewireTV

07.22.2026

The Latest EyewireTV

PRIMA Retinal Implant Launched in Europe Following CE Mark

B+L Launches EyeGility Inserter Preloaded IOL Delivery System in US

Update on Clinical Development Milestone

Stocks

Cataract

Canal-Based MIGS

It Is Not Good to Be Shallow

Interventional Glaucoma: A Collaborative Care Model for the Future of Glaucoma Management

MIGS Device Selection in Practice

Addressing Inflammatory Dry Eye

Elara 900: Reinventing the Clinical Workhorse

07.24.2026

Théa, Unither Pharmaceuticals Partner on Dedicated Ophthalmic Manufacturing Facility in France

07.21.2026

Pediatric Cataract Surgery May Alter Coordination of Ocular Growth, International Study Finds

07.21.2026

Fundamental XR, Orbis Report Early Success of VR Ophthalmic Training Program Across Africa

07.17.2026

Moorfields and University College London Launch CADMUS Anterior Segment Imaging Dataset

Refractive

PanOptix Pro IOL Patients Living Life Uninterrupted

Genetically Predisposed to Capsular Bag Instability

MIGS and Cataract Surgery

Addressing Inflammatory Dry Eye

Seeing More of the Cornea

It Is Not Good to Be Shallow

07.23.2026

iVeena Reports FDA Alignment on Phase 2 Development Plan for Pediatric Myopia Candidate IVMED-85

07.21.2026

Fundamental XR, Orbis Report Early Success of VR Ophthalmic Training Program Across Africa

07.17.2026

Moorfields and University College London Launch CADMUS Anterior Segment Imaging Dataset

07.17.2026

iVeena Reports Favorable Phase 1 Safety Data for Investigational Pediatric Myopia Therapy IVMED-85

Stay Updated

Follow Eyewire News

Retina

Retinal Perfusion, Sensitivity, and Function in DR

Monitoring Pulse During Direct PFCL/SO Exchange

Evolving Practice Patterns and Dosing Strategies in Geographic Atrophy

Spotlight on UNITY® VCS: Experience Extraordinary

Tecnis PureSee IOL Fully Launched in the US

Retinal Perfusion, Sensitivity, and Function in DR

07.27.2026

Aravind Eye Care System, Alcon Launch Global Vitreoretinal Surgery Training Center in India

07.24.2026

Topcon Receives CE Mark for GAIA Ultra-Widefield Retinal Imaging System

07.24.2026

Study: Mediterranean Diet Linked to Slower AMD Progression Across Disease Stages

07.24.2026

Tirzepatide Associated With Lower Risk of Diabetic Retinopathy Progression and Treatment

Glaucoma

Cataract Surgery and Hydrus Implantation

Endoscopic Cyclophotocoagulation

Viscodilation and Goniotomy With iTrack

Adding a Scleral Spacer

A Proposed Medicare Policy Would Tie Our Hands in the Fight Against Glaucoma

Shear Thinning and Collector Channels

07.27.2026

Glaukos Completes Enrollment in US Pivotal Study of Preserflo MicroShunt for POAG

07.24.2026

Théa, Unither Pharmaceuticals Partner on Dedicated Ophthalmic Manufacturing Facility in France

07.21.2026

Fundamental XR, Orbis Report Early Success of VR Ophthalmic Training Program Across Africa

07.17.2026

Glaucoma UK Launches Nationwide Patient Survey Targeting 10,000 Responses

Spotlight on UNITY^® VCS: Experience Extraordinary